When blood glucose levels are elevated, GLP-1 binding to beta-cell receptors triggers intracellular signaling cascades that enhance insulin synthesis and release
Even with all criteria met, denial rates remain highparticularly for newer agents like tirzepatide
Patients in the semaglutide group also lost a mean 9.4% of their body weight at 2 years
You may be a candidate for FDA-approved weight loss medication if: You have a BMI of 30 or greater
Semaglutide Microdosing for Individuals with Normal Weight While Semaglutide is primarily prescribed for overweight and obese individuals , microdosing has gained popularity among those with a normal BMI who struggle with appetite control, stubborn fat, or weight maintenance
Additionally, contact your prescribing clinician if gastrointestinal side effects significantly impact your quality of life or if you are considering stopping Wegovy due to these symptoms